'India has intellectual power to be a leader in biomedical innovation,' says Bayer AGBayer's CEO Bill Anderson believes India can become a top pharmaceutical market. He highlights the need for supportive policy frameworks, i...
Bayer's Asundexian drug reduces stroke risk by 26% in studyAsundexian reduced the chance of another stroke by 26% compared with placebo, when added to standard antiplatelet therapy such as Aspirin, ...
European shares recover as US rate-cut hopes lift sentiment; Ukraine talks in focusMeanwhile, the U.S. and Ukraine are set to continue work on a plan on Monday, after agreeing to modify an earlier proposal that was widely ...